Piramal Pharma Ii Private Limited, a active private limited company, was established on 08 June 2022 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2022PTC384232. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹34.01 Cr.
It upholds a compliant status. Its leadership includes Surinder Bhawanidas Gulati (Director), Amit Anant Bapat (Whole-Time Director). Past directors included Amit Anant Bapat. Its latest AGM occurred on 15 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gr. Flr, Ananta Building, Agastya Corp. Park, Kamani Junction, Lbs Marg, Kurla W, Mumbai, Maharashtra, 400070.
U24230MH2022PTC384232
384232
08 June 2022
₹50.00 Cr
₹34.01 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Piramal Pharma Ii Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surinder Bhawanidas Gulati | Director | 08 Jun 2022 | Current |
| Amit Anant Bapat | Whole-Time Director | 08 Jun 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Apr 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Piramal Pharma Ii's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Piramal Pharma Ii's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Piramal Pharma Ii has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Piramal Pharma Ii, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Piramal Pharma Ii's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Piramal Pharma Ii Private Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records. was recorded as a recent event.
Piramal Pharma Ii Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity Amit Anant Bapat was appointed as a CFO was appointed as a CFO on 30 May 2023 & has been associated with this company since 2 years 6 months . was completed.
Progress on Akshita Jain was appointed as a Company Secretary was appointed as a Company Secretary on 06 Mar 2023 & has been associated with this company since 2 years 9 months . was documented.
The activity Surinder Bhawanidas Gulati was appointed as a Director was appointed as a Director on 08 Jun 2022 & has been associated with this company since 3 years 5 months . was completed.
Amit Anant Bapat was appointed as a Whole-time director was appointed as a Whole-time director on 08 Jun 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.
When you realize Piramal Pharma Ltd made a 14% increase in revenue and a net profit of ₹10.11 crore in Q3FY24. Meanwhile, their CDMO, CHG, and India consumer healthcare divisions are all seeing growth and success. Nandini Piramal, the chairperson, is proud of their innovation and operational excellence. They also have a pipeline of 25 new products and are focused on sustainability and community development. #Winning #PiramalPharma #GrowthGoals.
The CIN of Piramal Pharma Ii Private Limited is U24230MH2022PTC384232.
Piramal Pharma Ii Private Limited is headquartered at Gr. Flr, Ananta Building, Agastya Corp. Park, Kamani Junction, Lbs Marg, Kurla W, Mumbai, Maharashtra, 400070.
Piramal Pharma Ii Private Limited was incorporated on 08 June 2022.
The current directors of Piramal Pharma Ii Private Limited are
The primary industry of Piramal Pharma Ii Private Limited is Pharma.
Piramal Pharma Ii Private Limited is unlisted.
The authorized capital of Piramal Pharma Ii Private Limited is ₹50.00 Cr, and the paid-up capital is ₹34.01 Cr.
The compliance status of Piramal Pharma Ii Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX